Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP519411.RAqFrQpUvjIUTw6vu6F9j31-_IVDXoVISQBZZSlJPRprw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP519411.RAqFrQpUvjIUTw6vu6F9j31-_IVDXoVISQBZZSlJPRprw130_assertion type Assertion NP519411.RAqFrQpUvjIUTw6vu6F9j31-_IVDXoVISQBZZSlJPRprw130_head.
- NP519411.RAqFrQpUvjIUTw6vu6F9j31-_IVDXoVISQBZZSlJPRprw130_assertion wasGeneratedBy ECO_0000203 NP519411.RAqFrQpUvjIUTw6vu6F9j31-_IVDXoVISQBZZSlJPRprw130_provenance.
- NP519411.RAqFrQpUvjIUTw6vu6F9j31-_IVDXoVISQBZZSlJPRprw130_assertion wasDerivedFrom befree-20150227 NP519411.RAqFrQpUvjIUTw6vu6F9j31-_IVDXoVISQBZZSlJPRprw130_provenance.
- NP519411.RAqFrQpUvjIUTw6vu6F9j31-_IVDXoVISQBZZSlJPRprw130_assertion SIO_000772 25671252 NP519411.RAqFrQpUvjIUTw6vu6F9j31-_IVDXoVISQBZZSlJPRprw130_provenance.
- NP519411.RAqFrQpUvjIUTw6vu6F9j31-_IVDXoVISQBZZSlJPRprw130_assertion evidence source_evidence_literature NP519411.RAqFrQpUvjIUTw6vu6F9j31-_IVDXoVISQBZZSlJPRprw130_provenance.
- NP519411.RAqFrQpUvjIUTw6vu6F9j31-_IVDXoVISQBZZSlJPRprw130_assertion description "[As compared with patients in whom the TET2 mutation was acquired first (hereafter referred to as 'TET2-first patients'), patients in whom the Janus kinase 2 (JAK2) mutation was acquired first ('JAK2-first patients') had a greater likelihood of presenting with polycythemia vera than with essential thrombocythemia, an increased risk of thrombosis, and an increased sensitivity of JAK2-mutant progenitors to ruxolitinib in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519411.RAqFrQpUvjIUTw6vu6F9j31-_IVDXoVISQBZZSlJPRprw130_provenance.